Atlas Trials

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

Clinical trial NCT01243073 · COMPLETED

Trial details

NCT number
NCT01243073
Sponsor
Geron Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Essential ThrombocythemiaPolycythemia Vera
Start date
2010-12-01
Primary completion
2013-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.